Impact of the Change in CMS Billing Rules for Erythropoietin on Hemoglobin Outcomes in Dialysis Patients

Publisher： Karger

E-ISSN： 1421-9735|25|1|31-35

ISSN： 0253-5068

Source： Blood Purification, Vol.25, Iss.1, 2006-12, pp. : 31-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Pre-Dialysis Care on Clinical Outcomes in Peritoneal Dialysis Patients

By  

American Journal of Nephrology, Vol. 43, Iss. 2, 2016-03 ,pp. : 104-111

Karger

Access to resources Recommend Favorite

Impact of Recombinant Human Erythropoietin Treatment on Left Ventricular Hypertrophy and Cardiac Function in Dialysis Patients

By  

Blood Purification, Vol. 16, Iss. 6, 1999-05 ,pp. : 317-324

Karger

Access to resources Recommend Favorite

Erythropoietin Hyporesponsiveness in Dialysis Patients: Possible Role of Statins

By  

American Journal of Nephrology, Vol. 46, Iss. 1, 2017-06 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

Efficacy of Erythropoietin on Dialysis in Patients with Beta Thalassemia Minor

By  

Blood Purification, Vol. 22, Iss. 5, 2004-11 ,pp. : 453-460

Karger

Access to resources Recommend Favorite

Association between Erythropoietin Responsiveness and Body Composition in Dialysis Patients

By  

Blood Purification, Vol. 26, Iss. 1, 2008-01 ,pp. : 82-89

Karger

Access to resources Recommend Favorite